Clinical impact of nocturnal ventricular tachyarrythmias in electrical storm

Pacing Clin Electrophysiol. 2022 Nov;45(11):1330-1337. doi: 10.1111/pace.14592. Epub 2022 Sep 28.

Abstract

Background: The incidence of electrical storm (ES) is significantly higher during the daytime. However, the association between nocturnal ventricular tachyarrythmias during ES and prognosis remains unclear. Therefore, this study aimed to investigate the clinical characteristics and outcomes of ES with midnight ventricular tachyarrythmias.

Methods: We included 48 consecutive patients who had an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator implanted between 2010 and 2020 and those who had experienced the onset of an out-of-hospital ES episode. According to the midnight (0:00 a.m.-6:00 a.m.) occurrence of ventricular arrythmia events consisting of ventricular tachycardia (VT) and ventricular fibrillation (VF), we divided them into two groups (with-midnight group: n = 27, without-midnight group: n = 21). The clinical characteristics and outcomes of the two groups were compared.

Results: The patients in the with-midnight group were mostly males, had longer QRS duration, and longer corrected QT-interval than those in the without-midnight group (p < .05). The incidence of all-cause death, especially heart failure death, was higher in the with-midnight group than in the without-midnight group (p < .01). Multivariate analysis showed that the presence of midnight VT/VF during ES was the only independent risk factors for heart failure death (HR = 18.9, 95%CI = 1.98-181, p = .011).

Conclusions: The presence of midnight VT/VF during ES might be associated with the poor prognosis. The loss of a sympathetic circadian pattern of VT/VF distribution during ES might suggest advanced stages of the cardiac disease.

Keywords: circadian variation; electrical storm (ES); implantable cardioverter-defibrillator (ICD); nocturnal.

MeSH terms

  • Arrhythmias, Cardiac / therapy
  • Cardiac Resynchronization Therapy* / adverse effects
  • Defibrillators, Implantable* / adverse effects
  • Female
  • Heart Failure* / therapy
  • Humans
  • Male
  • Risk Factors
  • Tachycardia, Ventricular* / etiology
  • Ventricular Fibrillation / etiology